About a week ago, FDA approved the very first treatment for patients with liver fibrosis caused by fatty liver disease.
Rezdiffra (resmetirom) is now approved for treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosis), […]
We are very excited to introduce our latest recruit to the Danish team!
Morten Johnsen recently joined us following the completion of his Masters in Quantitative Biology and Disease Modelling from DTU […]
Here are some of the things that makes our data unique:
1. Fast access to comprehensive data
In January 2024, the processing time at the Danish Health Data Authority decreased to just 34.9 days, providing swift access to a wealth of national-level […]
This week we have welcomed Jackie Moreno to the Stockholm office!
Following a career as a professional athlete and roles in account management Jackie will be working across units playing an integral part in sales and marketing strategies.
“The first week […]
We are thrilled to welcome Catarina Vitor Andersson to the Quantify team!
Catarina joins our Modelling, Access and Strategy Unit as a Senior Research Analyst.
Catarina has a background in Pharmacy and Health Economics and has worked in the past three […]
Recently, the 2023 ratings of Swedish Quality of care registers were made official and there are many top-rated registries within fields such as oncology, cardiovascular disease, infectious diseases, CNS and musculoskeletal diseases to name a few.
The Swedish disease-specific Quality of […]
Two renewed electronic catalogues of real-world data (RWD) sources and studies to enhance data discoverability have recently been launched by EMA and Heads of Human Medicines.
👉 The Catalogue of RWD Sources replaces the ENCePP Resources Database, offering a centralised repository […]
Welcome to the team Raphaela Mayerhofer, PhD.
Raphaela joins the RWE team in Stockholm following a career at Karolinska Institutet, Södertörn University, and the Medizinische Universität Graz, amongst others.
Alongside her academic career Raphaela […]
· What is it?
JCA is a streamlined EU-level process that evaluates the relative effectiveness and safety of new treatments compared to a range of alternative treatments. It considers a range of relevant treatments across EU member states. The […]
Quantify is proud to introduce Ana Buzatu, who will support our Model, Access, and Strategy team in Stockholm as a Junior Research Analyst.
Ana is a pharmacist currently pursuing a master’s degree in Health economics, Policy and Management at […]